NBIB-’223

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameNBIB-’223
Drug Alias NameNBIB-’223
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionFrataxin Gene transference
TargetsFrataxin, mitochondrial
Therapy Area/IndicationsFriedreich Ataxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeurocrine Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeurocrine Biosciences Inc
Inactive CompaniesN/A
Active IndicationsFriedreich Ataxia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A